MedTech Startup Summit and "MedTech Night" Party

eChinaHealth is an integrated media for China healthcare and pharmaceutical segments. eChinaHealth services include digital platform and media, conferences and events, data and consulting, and social network and community.

eChinaHealth, Inc.

Please download the 2019 JPMorgan Week eChinaHealth Conference Guide with conference agenda and speaker bio.
<A HREF="http://www.echinahealth.com/files/conference/1546571615-2019-JPMorgan-Week-eChinaHealth-Conference-Guide.pdf" DATA-MSYS-CLICKTRACK="0" REL="nofollow noopener noreferrer">Please click me</A>
 
January 8
MedTech Startup Summit
Global Funding for Today’s Medical Device and Diagnostics Startups: The Real Story
 
Organizers 
<IMG ALT="" SRC="https://cdn.evbuc.com/eventlogos/31077415/e5beaee4bfa1e688aae59bbe20181220093359.png">
Venue: JPMorgan Co., 560 Mission Street, 23rd Floor, San Francisco
Date:  Tuesday, January 8th, 2019
 
9:15 – 9:30  Registration 
 
Morning Session
Raising Capital from Overseas 
 
9:30 - 9 :45   Welcome and Opening Remarks
<UL>
<LI>Allan May, Chairman and Founder, Life Science Angels; Managing Partner, Emergent Medical Partners Venture Fund; General Partner, Woodside Medical China Incubator                      </LI>
</UL>
 
9:45 – 10:30   Raising Money Through Joint Ventures in China - Launching Product in China 
<SPAN STYLE="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-size: small;">More and more US companies are turning to China, both to raise capital and prepare for a first launch. The rewards can be rich, but ex-China companies have to play by certain rules and find partners who can help. In this session, we will explore how to create early-stage ventures in China with Chinese partners – and how not to.      
Moderator: 
<UL>
<LI>Allan May, Chairman and Founder, Life Science Angels; Managing Partner, Emergent Medical Partners Venture Fund; General Partner, Woodside Medical China Incubator. </LI>
</UL>
Panelists:
<UL>
<LI>Ty Hu, Managing Partner, Woodside Medical Accelerator; Managing Director, InnoVenture Medical Accelerator</LI>
<LI>Zihan Lin, Venture Partner, eChinaHealth; Managing Director, Perspective26; VP of Corporate Development, CardieX</LI>
<LI>Lixin Xu, Chairman of GIMDx</LI>
<LI>Nick Zhang, Board Chairman and CEO, QIAGEN (Suzhou) </LI>
</UL>
 
10:30 - 11:15   Raising Money From China – VC and Other Investors in US Startups
<SPAN STYLE="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">As capital from traditional US private investors becomes hard to find, many US start-ups are focusing their hopes on Chinese investors who are able and willing to invest in US companies. In this session, we will learn the best way to think about Chinese investment, how best to approach and vet Chinese investors, and how, if at all, Chinese investors differ from their US counterparts. 
Moderator:  
<UL>
<LI>Kingsley Lam, Greater China Desk, Vice President Multinational Corporations, J.P. Morgan </LI>
</UL>
Panelists:
<UL>
<LI>Alvin Syh, CEO of BC Asset Management</LI>
<LI>Lynn Yang, Managing Director, Sequoia Capital China</LI>
<LI>Ching Tan, Managing Partner, CD Capital</LI>
<LI>Alex Zhang, CEO, Hanhai BioLabs</LI>
</UL>
 
11:15 – 11:30   Coffee Break and Networking
 
11:30 – 12:15   Raising Money from Other Regions - Investing in Early Stage MedTech
<SPAN STYLE="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Today, most of the fund-raising efforts for medtech start-ups are concentrating on the US and China. But there is a whole other world out there and investors from a number of other geographies who are eager to invest in great companies. In this session, we will hear from investors from Europe, Israel, Taiwan, and other geographies about the venture scenes there.                       
Moderator:   
<UL>
<LI>David Cassak, Founder and Executive Editor, MedTech Strategist</LI>
</UL>
Panelists:
<UL>
<LI>Arthur Franken, Partner, Gilde Healthcare </LI>
<LI>Michal Geva, Founder and Managing Partner,  TriVentures </LI>
<LI>Yue-Teh Jang, Chairman and CEO,  Medeon Biodesign, Inc.</LI>
</UL>
 
12:15-1:15    Lunch and Networking 
 
Afternoon Sessions
 New Sources of Capital Impact MedTech Startups
 
1:00 – 2:00   Three Key Players Discuss What Is Really Going on With Funding in the U.S.
Finding capital for early stage MedTech continues to be challenging. Who is investing at the early stage? What do deals look like? How can a startup improve its prospects for raising capital?
<UL>
<LI>Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati</LI>
<LI>David Cassak, Founder and Executive Editor, MedTech Strategist</LI>
<LI>Allan May, Founder and Chairman, Life Science Angels; Managing Partner, Emergent Medical Partners Venture Fund; General Partner, Woodside Medical China Incubator</LI>
</UL>
 
2:00 – 2:15   Coffee Break and Networking
2:15 - 3:00    Provider Systems Emerge in Innovation Financing
<SPAN STYLE="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Healthcare systems are important customers for the technologies we develop. What happens when those customers are also investors in innovative technology? Can they re-shape the direction of technology development? As cost-constrained end-users, do they think differently about the kinds of devices they would like to see come to market?                        
Moderator:  
<UL>
<LI>David Cassak, Founder and Executive Editor, MedTech Strategist</LI>
</UL>
Panelists:
<UL>
<LI>Tara Butler, Managing Partner, Ascension Medical Partners</LI>
<LI>Luis Romo, Founder and CEO, PurpleSun </LI>
<LI>Jonathan Coe, Co-Founder, President & CEO, Prescient Surgical</LI>
</UL>
 
 
3:00 – 3:45  Strategic Investors and Structured Deals at the Early Stage 
<SPAN STYLE="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Once relegated to late-stage investments only, corporate investors are moving earlier in the funding cycle, while at the same time boosting the likelihood of an exit through structured deals that tee up an acquisition. But if there are enhanced opportunities in such deals, are there also enhanced risks?
Moderator:  
<UL>
<LI>Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati</LI>
</UL>
Panelists:
<UL>
<LI>Susan Lin, VP New Ventures and Business Devopment, LivaNova</LI>
<LI>James Eadie, Partner, Sante Ventures</LI>
<LI>Hanson Gifford, Managing Partner, The Foundry; Partner, Lightstone Ventures</LI>
</UL>
 
4:00 – 4:15   Coffee Break and Networking
 
4:15 – 5:00   Family Offices as Early Stage Investors – Natural Partners in Healthcare Investing 
<SPAN STYLE="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Family offices may be the latest in a host of alternative sources of capital for medtech start-ups. Often deep-pocketed investors, family offices bring a passionate commitment to their investments, but finding them can be difficult. In this session, several active family office investors talk about navigating the world of family offices.        
Moderators:  
<UL>
<LI>Kelly Marie McVearry, CEO, Hypatia Group; Chairman, Lupus Therapeutics</LI>
<LI>Allan May, Chairman and Founder, Life Science Angels; Managing Partner, Emergent Medical Partners Venture Fund, General Partner; Woodside Medical Management China Incubator</LI>
</UL>
Panelists:
<UL>
<LI>Kevin Schimmelfetig, Managing Partner, McGeever Family Office</LI>
<LI>Gini Deshpande, Founder and CEO, NuMedii, capital formation by Three Lakes Partners</LI>
<LI>Melissa Stevens, Executive Director, Milken Center for Strategic Philanthropy, and former Executive Director of Milken FasterCures.</LI>
<LI>Greg Garfield, Senior Managing Director at KCK Group - Medical Technologies </LI>
</UL>
  
"MedTech Night" 
(300-400 people)
6:00 - 8:30        Cocktail Reception 
Venue:   SLIIC Rooftop Garden, 755 Sansome Street
 <IMG ALT="" SRC="https://cdn.evbuc.com/eventlogos/31077415/timg281329.jpg" HEIGHT="337" WIDTH="600">
Sponsored by Wilson Sonsini Goodrich & Rosati, MedTech Strategist

JPMorgan Co. 23rd Floor Conference Room

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

MedTech Startup Summit and "MedTech Night" Party

More events from eChinaHealth, Inc.

Discover more events from eChinaHealth, Inc., from Business to other experiences you might love.

MedTech Startup Summit and "MedTech Night" Party

More events from eChinaHealth, Inc.

Discover more events from eChinaHealth, Inc., from Business to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.